Model for End-Stage Liver Disease (MELD) exception for cholangiocarcinoma or biliary dysplasia

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

  Gores, Gregory J ^a   Gish, Robert G ^b   Sudan, Debra ^c   Rosen, Charles B ^a  

^a Mayo Clinic   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; DYSPLASIA; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; PRACTICE GUIDELINE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; UNITED STATES;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT; CHOLANGIOCARCINOMA; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT;

EID: 33845507539     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20965     Document Type: Article

References (10)

1. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004;99: 523-526.
2. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004;66:167-179.
3. Farley DR, Weaver AL, Nagorney DM. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995;70:425-429.
4. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69:1633-1637.
5. Robles R, Figuieras J, Turrion VS, Margarit C, Moya A, Varo E, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004;239:265-271.
6. Ghali P, Marotta PJ, Yoshida EM, Bain VG, Marleua D, Peltekian K, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl 2005; 11: 1412-1416.
7. Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B Jr, McCashland T, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002;2:774-779.
8. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004; 24:201-207.
9. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-461.
10. Rosen CB. MELD exceptions for hilar cholangiocarcinoma and biliary dysplasia. Paper presented at: MELD Exception Study Group; March 1-2, 2006; Chicago, IL.